IL145609A0 - Combination preparation for treating malaria - Google Patents

Combination preparation for treating malaria

Info

Publication number
IL145609A0
IL145609A0 IL14560900A IL14560900A IL145609A0 IL 145609 A0 IL145609 A0 IL 145609A0 IL 14560900 A IL14560900 A IL 14560900A IL 14560900 A IL14560900 A IL 14560900A IL 145609 A0 IL145609 A0 IL 145609A0
Authority
IL
Israel
Prior art keywords
combination preparation
treating malaria
malaria
treating
proguanil
Prior art date
Application number
IL14560900A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL145609A0 publication Critical patent/IL145609A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL14560900A 1999-04-09 2000-04-05 Combination preparation for treating malaria IL145609A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12867299P 1999-04-09 1999-04-09
PCT/US2000/009091 WO2000061133A1 (en) 1999-04-09 2000-04-05 Combination preparation for treating malaria

Publications (1)

Publication Number Publication Date
IL145609A0 true IL145609A0 (en) 2002-06-30

Family

ID=22436426

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14560900A IL145609A0 (en) 1999-04-09 2000-04-05 Combination preparation for treating malaria
IL145609A IL145609A (en) 1999-04-09 2001-09-24 Preparation of a combination preparation for the treatment of malaria

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL145609A IL145609A (en) 1999-04-09 2001-09-24 Preparation of a combination preparation for the treatment of malaria

Country Status (23)

Country Link
US (1) US6413993B1 (de)
EP (1) EP1171108B1 (de)
JP (1) JP2002541196A (de)
KR (1) KR100613805B1 (de)
CN (1) CN1152676C (de)
AT (1) ATE241971T1 (de)
AU (1) AU758167B2 (de)
BR (1) BR0009676A (de)
CA (1) CA2369089A1 (de)
CZ (1) CZ294903B6 (de)
DE (1) DE60003175T2 (de)
DK (1) DK1171108T3 (de)
ES (1) ES2199817T3 (de)
HU (1) HUP0200842A3 (de)
IL (2) IL145609A0 (de)
MX (1) MXPA01010125A (de)
NO (1) NO20014806L (de)
NZ (1) NZ514353A (de)
PL (1) PL350987A1 (de)
PT (1) PT1171108E (de)
TR (1) TR200102843T2 (de)
WO (1) WO2000061133A1 (de)
ZA (1) ZA200108254B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
KR20110010763A (ko) * 2008-05-09 2011-02-07 톨마 인코포레이티드 피부/점막 질환을 치료하기 위한 프로구아닐
CN102105427A (zh) * 2008-07-25 2011-06-22 阿尔法制药有限公司 粒度直径范围(D90)为大于3μm至约10μm的阿托伐醌
EP2467358B1 (de) 2009-08-20 2014-07-23 IPCA Laboratories Limited Neuer komplex zur behandlung und/oder prophylaxe von parasiteninfektionen
EP3415147B1 (de) * 2016-02-12 2025-04-02 Kao Corporation Melaninabbauhemmer
WO2018067882A1 (en) * 2016-10-05 2018-04-12 Titan Pharmaceuticals, Inc. Implantable devices for drug delivery with reduced burst release
WO2018204563A1 (en) * 2017-05-03 2018-11-08 The Johns Hopkins University Intramuscular atovaquone for malaria prophylaxis
CN107737108B (zh) * 2017-12-17 2018-06-26 姚蕾 一种治疗心肌梗死后心室重塑的口服药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
JPH0873355A (ja) * 1994-09-02 1996-03-19 Mitsui Toatsu Chem Inc 抗マラリア薬耐性克服剤

Also Published As

Publication number Publication date
IL145609A (en) 2006-04-10
CN1346267A (zh) 2002-04-24
HK1041638A1 (en) 2002-07-19
AU4202200A (en) 2000-11-14
MXPA01010125A (es) 2002-06-04
ATE241971T1 (de) 2003-06-15
NO20014806D0 (no) 2001-10-03
CZ294903B6 (cs) 2005-04-13
BR0009676A (pt) 2002-09-03
KR20010108468A (ko) 2001-12-07
WO2000061133A1 (en) 2000-10-19
ES2199817T3 (es) 2004-03-01
NO20014806L (no) 2001-12-05
EP1171108A1 (de) 2002-01-16
TR200102843T2 (tr) 2002-01-21
CN1152676C (zh) 2004-06-09
EP1171108B1 (de) 2003-06-04
CA2369089A1 (en) 2000-10-19
DE60003175T2 (de) 2004-04-01
CZ20013646A3 (cs) 2002-06-12
AU758167B2 (en) 2003-03-20
JP2002541196A (ja) 2002-12-03
HUP0200842A3 (en) 2006-07-28
US6413993B1 (en) 2002-07-02
DK1171108T3 (da) 2003-10-06
KR100613805B1 (ko) 2006-08-18
ZA200108254B (en) 2003-03-26
PL350987A1 (en) 2003-02-24
DE60003175D1 (de) 2003-07-10
HUP0200842A2 (hu) 2002-07-29
PT1171108E (pt) 2003-10-31
NZ514353A (en) 2003-10-31

Similar Documents

Publication Publication Date Title
EP1634601A3 (de) Nahrungsergänzungsmittel, enthaltend Soja, Pilz und Mungobohne
GEP20053602B (en) Aripiprazole for Oral Administration
MY113059A (en) Controlled-release dosage forms of azithromycin
MXPA03003960A (es) Combinaciones de farmacos (v.gr., clorpromazina y pentamidina) para el tratamiento de desordenes neoplasticos.
CZ2000531A3 (en) Method of prevention or therapy of estrogen-dependent diseases and disorders
PT998287E (pt) Utilizacao de levobupivacaina
IL145609A0 (en) Combination preparation for treating malaria
AU1167602A (en) Methods of therapy for hiv infection
MXPA02012064A (es) Complejos de farmaco macromoleculares y composiciones que los contienen.
MY134690A (en) Antitumor therapy comprising distamycin derivatives.
IL159770A0 (en) Calcium salts with cytotoxic activity
WO2001076590A3 (en) Treatment for benign positional vertigo using antiepileptics
USD467344S1 (en) Treatment couch
MXPA03000033A (es) Procedimiento de tratamiento de enfermedades vasculares perifericas, neuropatias perifericas y neuropatias autonomicas.
EP1143981A4 (de) Behandlung und vorbeugung von hiv- und anderen virus infektionen
EP1347754A4 (de) Zusammensetzungen zur verhinderung der adhäsion
AU2450900A (en) Therapeutic nucleoside compound
PL367628A1 (en) Use of an alkanoyl l-carnitine for the preparation of a medication to treat anhedonia
WO2003059334A3 (en) Gemcitabine in the treatment of smallpox
IL139064A0 (en) Intermittent claudication therapeutic drugs comprising pyrroloazepines
陈沛泉 et al. THE INFECTIVITY OF GAMETOCYTES OF PLASMODIUM FALCIPARUM FROM PATIENTS TREATED WITH ARTEMISININ
MD1469F1 (en) Method of treatment of the burn shock
EP1908477A3 (de) Kombination aus Temozolomid und pegyliertem Interferon-alpha zur Krebsbehandlung
UA33498A (uk) Спосіб лікування терапевтично резистентних форм шизофренії
JO1462B1 (en) Mixture preparations for the treatment of malaria

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed